Association of CA Repeat Polymorphism in Estrogen Receptor β Gene with Postmenopausal Osteoporosis in Chinese

Li Geng; Zhenwei Yao; Hongchang Yang; Jianyun Luo; Lili Han; Qi Lu

doi:10.1016/S1673-8527(07)60098-8

Volume 34 Issue 10

Oct. 2007

Turn off MathJax

Article Contents

Article Navigation > Journal of Genetics and Genomics > 2007 > 34(10): 868-876

PDF( 550 KB)

Association of CA Repeat Polymorphism in Estrogen Receptor β Gene with Postmenopausal Osteoporosis in Chinese

doi: 10.1016/S1673-8527(07)60098-8

a
Department of Obstetrics and Gynecology, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China
b
Trauma Center of Yunnan Province, Kunming 650021, China

More Information

Corresponding author: E-mail address: zhen4628@sina.com (Zhenwei Yao)
Received Date: 2007-03-26
Accepted Date: 2007-06-05

Available Online: 2007-10-16

Publish Date: 2007-10-20

Abstract

Abstract

Postmenopausal osteoporosis (PMO) is considered a polygenic disease. The estrogen receptor β (ESR2) gene is a candidate mediating the genetic influence on bone mass and the risk of osteoporosis. The aim of this study is to investigate the association of a cytosine-adenine (CA) repeat polymorphism in the fifth intron of the ESR2 gene with PMO in Chinese Han population. The CA repeat polymorphism was genotyped in a case-control study, involving 78 femoral neck PMO patients vs. 122 controls and 108 lumbar spine (L2-4) PMO patients vs. 92 controls. The (CA)_n < 22 and (CA) _n ≥ 22 alleles were designated short (S) and long (L), respectively. ESR2 genotype was categorically defined as SS (2 S alleles), SL (having the mixed S and L alleles), and LL (2 L alleles). At both the femoral neck and the L2-4 region, LL genotype and L allele frequencies of the PMO group were significantly higher than those of the control group ( P < 0.01). The subjects with the SL, the LL, and the combined SL and LL genotype had a significant increased risk of PMO when compared with those with the SS genotype ( P < 0.05). After adjustments for age, years since menopause, menopausal age, and body mass index, logistic regression analysis showed that the subjects with the combined SL and LL genotype had increased risk of PMO when compared with those with the SS genotype both at the femoral neck (adjusted OR 4.923, 95% CI 1.986–12.203, P=0.001) and the L2-4 (adjusted OR 2.267, 95% CI 1.121–4.598, P=0.023). This extensive association study has identified the ESR2 CA repeat polymorphism to be independently associated with PMO at the femoral neck and the L2-4 in Chinese Han population. The data also suggested that the presence of the L allele may dominantly increase the risk of PMO at the two regions.
- osteoporosis,
- postmenopausal,
- polymorphisms,
- bone mineral density

FullText(HTML)

References(27)

References

[1]	Devoto, M, Shimoya, et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4p Eur J Hum Genet, 6 (1998),pp. 151-157
[2]	Econs, MJ, Koller, et al. Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women Am J Hum Genet, 74 (2004),pp. 223-228
[3]	Morrison, NA, Qi, et al. Prediction of bone density from vitamin D receptor alleles Nature, 367 (1994),pp. 284-287
[4]	Uitterlinden, AG, Burger, et al. Relation of alleles of the collagen type Iα1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women N Engl J Med, 338 (1998),pp. 1016-1021
[5]	Yamada, Y, Ando, et al. Transforming growth factor- beta1 gene polymorphism and bone mineral density JAMA, 285 (2001),pp. 167-168
[6]	Braidman, IP, Hainey, et al. Localization of estrogen receptor beta protein expression in adult human bone J Bone Miner Res, 16 (2001),pp. 214-220
[7]	Batra, GS, Hainey, et al. Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women J Pathol, 200 (2003),pp. 65-73
[8]	Kuiper, GG, Gustafasson, et al. The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens FFBS Lett, 410 (1997),pp. 87-90
[9]	Mosselman, S, Polman, et al. ER beta: identification and characterization of a novel human estrogen receptor FEBS Lett, 392 (1996),pp. 49-53
[10]	Onoe, Y, Miyaura, et al. Expression of estrogen receptor beta in rat bone Endocrinology, 138 (1997),pp. 4509-4512
[11]	Lim, SK, Won, et al. A PCR analysis of ERalpha and ERbeta mRNA abundance in rats and the effect of ovariectomy J Bone Miner Res, 14 (1999),pp. 1189-1196
[12]	Bord, S, Horner, et al. Estrogen receptors alpha and beta are differentially expressed in developing human bone J Clin Endocrinol Metab, 86 (2001),pp. 2309-2314
[13]	Vidal, O, Lindberg, et al. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice Proc Natl Acad Sci USA, 97 (2000),pp. 5474-5479
[14]	Lindberg, MK, Alatalo, et al. Estrogen receptor specificity in the regulation of the skeleton in female mice J Endocrinol, 171 (2001),pp. 229-236
[15]	Chagin, AS, Lindberg, et al. Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice J Bone Miner Res, 19 (2004),pp. 72-77
[16]	Hall, JM, McDonnell, et al. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens Endocrinology, 140 (1999),pp. 5566-5578
[17]	Lindberg, MK, Moverare, et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice Mol Endocrinol, 17 (2003),pp. 203-208
[18]	Tsukamoto, K, Inoue, et al. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus J Hum Genet, 43 (1998),pp. 73-74
[19]	Ogawa, S, Hosoi, et al. Association of estrogen receptor beta gene polymorphism with bone mineral density Biochem Biophys Res Commun, 269 (2000),pp. 537-541
[20]	Lau, HH, Ho, et al. Estrogen receptor beta gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern Chinese women Bone, 31 (2002),pp. 276-281
[21]	Kanis, JA, Melton, et al. The diagnosis of osteoporosis J Bone Miner Res, 9 (1994),pp. 1137-1141
[22]	Schiffner, LA, Bajda, et al. Optimization of a simple, automatable extraction method to recover sufficient DNA from low copy number DNA samples for generation of short tandem repeat profiles Croat Med J, 46 (2005),pp. 578-586
[23]	Westberg, L, Baghaei, et al. Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women J Clin Endocrinol Metab, 86 (2001),pp. 2562-2568
[24]	Tothill, P, Laskey, et al. Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instrument Br J Radiol, 72 (1999),pp. 661-669
[25]	Gennari, L, Merlotti, et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a huge review Am J Epidemiol, 161 (2005),pp. 307-320
[26]	Scariano, JK, Simplicio, et al. Estrogen receptor beta dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women Calcif Tissue Int, 74 (2004),pp. 501-508
[27]	Shearman, AM, Karasik, et al. Estrogen receptor beta polymorphisms are associated with bone mass in women and men: the framingham study J Bone Miner Res, 19 (2004),pp. 773-781